Encuesta Presidencial EPCH – Segunda vuelta presidencial – Septiembre 2025
La elección presidencial de Chile para el período 2026-2030 se realizará el domingo 16 de noviembre del presente año 2025.
Encuesta presidencial EPCH, segunda vuelta presidencial, se realizará entre todos los candidatos (Jeannette Jara, Franco Parisi, José Antonio Kast, Evelyn Matthei, Harold Mayne-Nicholls y Johannes Kaiser).
Las elecciones presidenciales se realizarán el 16 de noviembre de este año 2025, si ningún candidato obtiene más del 50% de los votos, la elección se definirá el 14 de diciembre del mismo año, en una segunda vuelta presidencial.
Es importante recordar que el voto el obligatorio para las 3 elecciones de este año, se elegirán a diputados, senadores y presidente.
Los candidatos son:
Jeannette Jara, Partido Comunista de Chile.
José Antonio Kast, Partido Republicano de Chile.
Las opciones de esta hipotética segunda vuelta presidencial son las siguientes:
- Jeannette Jara – PC
- José Antonio Kast – Republicano
A continuación podrás votar por una de las siguientes 2 opciones:
*Debe apretar en un nombre para votar (no apriete en la cara).
La encuesta finalizará el día martes 30 de septiembre, a las 23:59 horas, por lo tanto la votación se cerrará automáticamente.
*Si quieres participar en alguna de nuestras encuestas, nos puedes contactar a nuestro WhatsApp:
Kast
Nunca comunista
Kast
PIRQUE SOY PROFESIONAL , PIRQUE SOY CHILENO ; PIRQUE AMO A MI PUEBLO ….SIEMPRE COMUNISTA !
KAST…ARRIBA SIEMPRE
Jara
Jara
Por Jeanette Jara de toda maneras
Nuevamente el mal menor: Jara
El centro es el Equilibrio! Voy por #FRANCOPARISIPRESIDENTE
Da Tristeza ver como la gente está siendo manipulada para elegir entre 2 opciones. Izquierda o Derecha. A Franco Parisi lo hacen mierda siempre!! Por que es el único capas de terminar con la Casta política Ladrona que se creen dueños de CHILE! El Profe no le debe favores Politicos a nadie! Asi que sean conscientes y voten Inteligente! Voten por #FRANCOPARISIPRESIDENTE!!! Vamos por un cambio Real! 💪 💪 💪.
Kast
Jeanette Jara presidenta
Todo el tiempo Jara, el otro Nóos llevará a estar como Argentina
Kaiser me gusta,pero si Kast pasa a segunda vuelta obvio que por Kast
Jara
Kast nunca comunista
Jara
Kast
prefiero votar por un burro antes que un comunista
Obvio Jamás Comunista nuevamente 🙏🙏🙏🙏
Por Kast… Les recomiendo que vean el ejemplo de Venezuela…. Uno de los países más rico de Latinoamérica gobernado por un comunista….. Así son ellos, gobiernan para destruir a su pueblo y llenarse los bolsillos…. No creo que quieran un comunista más en Chile
En verdad no tienes idea de política internacional y menos nacional. En Chile Nunca ha gobernado el comunismo, incluso Jara está en un conglomerado donde uno de los partidos es el comunista, ella no gobernará sola si es que sale. Chile nunca ha sido ni será Venezuela
En serio Kast???… cuales son sus credenciales? Seguir el ejemplo del corrupto y empobrecedor de Milei?, 16 años en la cámara de diputados sin contribuir con una sola ley?… Mentir siempre???
Ipamorelin Side Effects Safety And Risks Explained
Ipamorelin Side Effects
When used as prescribed, ipamorelin is generally well tolerated,
yet users may experience several side effects.
The most common reactions involve mild injection site
discomfort such as pain, redness, or swelling that typically resolves within a few hours.
Some individuals report transient headaches or dizziness shortly after administration, likely
linked to altered blood flow dynamics. A small subset of people may notice temporary fatigue or a feeling of lethargy, especially when the peptide is first
introduced into their regimen.
More pronounced but less frequent side effects include increased appetite and subsequent weight gain. This occurs
because ipamorelin stimulates growth hormone secretion, which can enhance anabolic processes.
Hormonal changes may also lead to mood swings or irritability in some users.
In rare cases, there have been reports of mild edema or fluid retention, a topic addressed further below.
About Ipamorelin
Ipamorelin is a synthetic peptide that belongs to the class of growth hormone secretagogues (GHS).
Developed to mimic natural ghrelin activity, it selectively stimulates the
release of growth hormone from the pituitary gland without significantly affecting other hormones such as cortisol or prolactin. Because of its high specificity
and potency, ipamorelin is favored in clinical settings for treating growth hormone deficiencies and
in sports medicine for muscle recovery.
Unlike many older GHS agents that may cause nausea or significant hormonal imbalances, ipamorelin’s design minimizes these drawbacks while maintaining robust efficacy.
Its short half‑life allows precise dosing schedules,
and it can be administered via subcutaneous injection. The peptide is available as a sterile solution ready for use in both therapeutic and research contexts.
Mechanism of Action
Ipamorelin exerts its effect by binding to the growth hormone
secretagogue receptor type 1a (GHSR‑1a) located on somatotrophic cells within the anterior pituitary.
This binding activates intracellular signaling cascades—primarily through Gq protein coupling—that lead to phospholipase C activation, increased intracellular calcium, and
ultimately secretion of growth hormone into circulation.
What sets ipamorelin apart is its minimal impact on other endocrine
pathways. It does not appreciably stimulate the hypothalamic-pituitary-adrenal axis or alter thyroid function,
which reduces potential side effects such as cortisol excess or thyroid hormone disturbances.
The peptide’s selective action results in a cleaner hormonal
profile, enabling clinicians to target growth hormone
deficits without widespread endocrine disruption.
Molecular Structure of Ipamorelin
Ipamorelin is a hexapeptide composed of the amino acid sequence: N‑Acetyl‑pro‑homo‑gly‑pyr‑l‑tyr‑Ala‑Gly.
The acetyl group at the N‑terminus protects the peptide from
enzymatic degradation, enhancing its stability in vivo. Each
residue is chosen to optimize receptor affinity and metabolic resistance.
The structure includes a unique proline-homocysteine
pair that confers conformational rigidity, promoting selective
binding to GHSR‑1a. The C‑terminal glycine allows for
efficient synthesis via solid-phase peptide
assembly, while the aromatic tyrosine contributes
to hydrophobic interactions essential for receptor engagement.
Overall, ipamorelin’s compact and stable design underlies its rapid onset and potent action.
Possible Side Effects of Ipamorelin
Although generally safe, ipamorelin can produce a range of side effects depending on dosage, frequency, and individual sensitivity.
Common concerns include:
Injection site reactions: pain, redness, or mild swelling.
Transient headaches or dizziness, often resolved within hours.
Increased appetite leading to weight gain if caloric intake is not
managed.
Mood changes such as irritability or mood swings due to
hormonal shifts.
Fluid retention and mild edema in some patients.
These effects are usually reversible upon discontinuation or dose
adjustment. Rarely, more serious complications such as
severe allergic reactions or significant hormonal imbalances may occur, underscoring the importance
of medical supervision during therapy.
Water Retention
Water retention associated with ipamorelin is typically mild and manifests
as peripheral edema, especially in the extremities. The underlying mechanism involves growth hormone’s influence on sodium handling within the kidneys and its effect on vascular permeability.
Clinicians often advise patients to monitor fluid intake, maintain a balanced diet, and use
compression garments if swelling becomes bothersome.
Monitoring electrolytes can help detect any significant shifts that might accompany fluid retention. Adjusting the dosing schedule or adding diuretics under medical guidance may mitigate
this side effect without compromising therapeutic benefits.
Safety
ipamorelin side effect’s safety profile is favorable compared to older GHS analogues,
primarily because it spares cortisol and prolactin pathways.
Clinical trials have shown no significant increase in blood pressure, heart
rate, or adverse metabolic effects when used within recommended dosages.
Nevertheless, patients with pre‑existing endocrine disorders, liver disease, or renal
impairment should undergo thorough evaluation before initiating
therapy.
Long‑term safety data are limited; however, short‑to‑medium term studies indicate that
ipamorelin does not induce tumor growth or significant immunogenic
responses. Nonetheless, ongoing surveillance for potential adverse effects remains essential, especially
in off‑label use scenarios such as athletic performance enhancement.
More about Ipamorelin peptide
Beyond its therapeutic role, ipamorelin is frequently studied in regenerative
medicine and anti‑aging research. Its capacity to elevate endogenous growth hormone supports tissue repair, collagen synthesis,
and metabolic modulation. Research explores combining ipamorelin with other peptides or nutritional interventions to amplify benefits while reducing side effect risk.
In veterinary applications, ipamorelin has shown promise for treating age‑related
decline in animals, though regulatory approvals vary by region. Its use as a
research tool also extends into basic science studies examining the
neuroendocrine regulation of growth hormone secretion and its
downstream effects on metabolism and aging.
Ipamorelin – Dosage
Standard dosing regimens typically involve 100–200 micrograms administered subcutaneously two to three times daily, spaced approximately four hours apart.
For therapeutic purposes such as treating growth hormone deficiency, clinicians may
begin at the lower end of this range and titrate upward
based on serum hormone levels and clinical response.
Athletic or anti‑aging protocols often employ higher cumulative doses—up
to 300–400 micrograms per day—split across multiple
injections. However, these regimens increase the likelihood of side effects like increased appetite or fluid retention. It is crucial to monitor
hormonal markers (growth hormone, IGF‑1) and
adjust dosage accordingly.
When initiating ipamorelin therapy, patients should receive
guidance on injection technique, storage conditions,
and potential interactions with other medications.
Regular follow‑up appointments help ensure optimal dosing
while minimizing adverse reactions.
Anabolic Steroids: Types, Uses, And Risks
References:
what is a good dianabol cycle
Anavar 30mg A Day Results, Anavar 30mg Cycle
Sure thing! Could you let me know what specific list you’re looking for?
For example, do you need a list of workouts, a nutrition plan outline, or something else entirely?
I went over this internet site and I think you have a lot of good info , saved to my bookmarks (:.